vs

Side-by-side financial comparison of INTERGROUP CORP (INTG) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

AVITA Medical, Inc. is the larger business by last-quarter revenue ($17.6M vs $17.3M, roughly 1.0× INTERGROUP CORP). INTERGROUP CORP runs the higher net margin — 8.8% vs -66.0%, a 74.7% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs -4.3%). INTERGROUP CORP produced more free cash flow last quarter ($-481.0K vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 7.8%).

Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

INTG vs RCEL — Head-to-Head

Bigger by revenue
RCEL
RCEL
1.0× larger
RCEL
$17.6M
$17.3M
INTG
Growing faster (revenue YoY)
INTG
INTG
+24.1% gap
INTG
19.8%
-4.3%
RCEL
Higher net margin
INTG
INTG
74.7% more per $
INTG
8.8%
-66.0%
RCEL
More free cash flow
INTG
INTG
$5.6M more FCF
INTG
$-481.0K
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
7.8%
INTG

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
INTG
INTG
RCEL
RCEL
Revenue
$17.3M
$17.6M
Net Profit
$1.5M
$-11.6M
Gross Margin
81.2%
Operating Margin
11.6%
-59.1%
Net Margin
8.8%
-66.0%
Revenue YoY
19.8%
-4.3%
Net Profit YoY
155.6%
-0.3%
EPS (diluted)
$0.71
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INTG
INTG
RCEL
RCEL
Q4 25
$17.3M
$17.6M
Q3 25
$17.9M
$17.1M
Q2 25
$16.2M
$18.4M
Q1 25
$16.8M
$18.5M
Q4 24
$14.4M
$18.4M
Q3 24
$16.9M
$19.5M
Q2 24
$13.4M
$15.2M
Q1 24
$14.9M
$11.1M
Net Profit
INTG
INTG
RCEL
RCEL
Q4 25
$1.5M
$-11.6M
Q3 25
$-535.0K
$-13.2M
Q2 25
$-2.2M
$-9.9M
Q1 25
$-578.0K
$-13.9M
Q4 24
$-2.7M
$-11.6M
Q3 24
$-398.0K
$-16.2M
Q2 24
$-4.9M
$-15.4M
Q1 24
$-3.2M
$-18.7M
Gross Margin
INTG
INTG
RCEL
RCEL
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
Q1 24
86.4%
Operating Margin
INTG
INTG
RCEL
RCEL
Q4 25
11.6%
-59.1%
Q3 25
15.3%
-53.6%
Q2 25
8.1%
-60.5%
Q1 25
14.0%
-63.9%
Q4 24
5.9%
-54.1%
Q3 24
18.5%
-70.6%
Q2 24
3.7%
-102.8%
Q1 24
4.8%
-155.0%
Net Margin
INTG
INTG
RCEL
RCEL
Q4 25
8.8%
-66.0%
Q3 25
-3.0%
-77.3%
Q2 25
-13.9%
-53.9%
Q1 25
-3.4%
-74.9%
Q4 24
-18.9%
-63.0%
Q3 24
-2.4%
-82.9%
Q2 24
-36.7%
-101.3%
Q1 24
-21.3%
-168.0%
EPS (diluted)
INTG
INTG
RCEL
RCEL
Q4 25
$0.71
$-0.37
Q3 25
$-0.25
$-0.46
Q2 25
$-0.38
Q1 25
$-0.27
$-0.53
Q4 24
$-1.26
$-0.44
Q3 24
$-0.18
$-0.62
Q2 24
$-0.60
Q1 24
$-1.44
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INTG
INTG
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$7.5M
$18.2M
Total DebtLower is stronger
$233.2M
Stockholders' EquityBook value
$-85.2M
$-16.6M
Total Assets
$101.1M
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INTG
INTG
RCEL
RCEL
Q4 25
$7.5M
$18.2M
Q3 25
$6.0M
$23.3M
Q2 25
$6.1M
$15.7M
Q1 25
$4.8M
$25.8M
Q4 24
$15.4M
$35.9M
Q3 24
$12.2M
$44.4M
Q2 24
$11.6M
$54.1M
Q1 24
$19.5M
$68.2M
Total Debt
INTG
INTG
RCEL
RCEL
Q4 25
$233.2M
Q3 25
$237.8M
Q2 25
$240.5M
Q1 25
$241.5M
Q4 24
$227.2M
Q3 24
$218.1M
Q2 24
$225.7M
Q1 24
$225.0M
Stockholders' Equity
INTG
INTG
RCEL
RCEL
Q4 25
$-85.2M
$-16.6M
Q3 25
$-86.7M
$-6.7M
Q2 25
$-86.1M
$-12.9M
Q1 25
$-84.5M
$-4.6M
Q4 24
$-83.9M
$4.5M
Q3 24
$-80.9M
$12.2M
Q2 24
$-80.3M
$23.9M
Q1 24
$-76.4M
$32.6M
Total Assets
INTG
INTG
RCEL
RCEL
Q4 25
$101.1M
$56.4M
Q3 25
$102.5M
$63.7M
Q2 25
$104.1M
$58.1M
Q1 25
$103.2M
$69.6M
Q4 24
$110.6M
$79.7M
Q3 24
$109.3M
$81.1M
Q2 24
$107.8M
$87.8M
Q1 24
$119.0M
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INTG
INTG
RCEL
RCEL
Operating Cash FlowLast quarter
$-23.0K
$-5.4M
Free Cash FlowOCF − Capex
$-481.0K
$-6.1M
FCF MarginFCF / Revenue
-2.8%
-34.7%
Capex IntensityCapex / Revenue
2.6%
3.8%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters
$739.0K
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INTG
INTG
RCEL
RCEL
Q4 25
$-23.0K
$-5.4M
Q3 25
$-296.0K
$-5.2M
Q2 25
$5.9M
$-10.2M
Q1 25
$-854.0K
$-10.3M
Q4 24
$-781.0K
$-8.1M
Q3 24
$3.4M
$-7.2M
Q2 24
$6.8M
$-12.8M
Q1 24
$1.9M
$-20.9M
Free Cash Flow
INTG
INTG
RCEL
RCEL
Q4 25
$-481.0K
$-6.1M
Q3 25
$-1.3M
$-6.2M
Q2 25
$3.6M
$-10.8M
Q1 25
$-1.2M
$-10.5M
Q4 24
$-1.1M
$-9.7M
Q3 24
$3.1M
$-11.0M
Q2 24
$2.7M
$-15.4M
Q1 24
$1.1M
$-22.0M
FCF Margin
INTG
INTG
RCEL
RCEL
Q4 25
-2.8%
-34.7%
Q3 25
-7.1%
-36.1%
Q2 25
22.5%
-58.4%
Q1 25
-6.8%
-56.9%
Q4 24
-7.8%
-52.7%
Q3 24
18.3%
-56.1%
Q2 24
20.4%
-101.6%
Q1 24
7.6%
-198.2%
Capex Intensity
INTG
INTG
RCEL
RCEL
Q4 25
2.6%
3.8%
Q3 25
5.4%
5.5%
Q2 25
13.9%
2.8%
Q1 25
1.8%
1.2%
Q4 24
2.4%
8.8%
Q3 24
1.6%
19.2%
Q2 24
30.4%
17.5%
Q1 24
4.9%
10.3%
Cash Conversion
INTG
INTG
RCEL
RCEL
Q4 25
-0.02×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INTG
INTG

Hotel Operations$12.7M73%
Real Estate Operation$4.6M27%

RCEL
RCEL

Segment breakdown not available.

Related Comparisons